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Abstract: Aberrant extracellular matrix (ECM) remodelling in muscle, liver and adipose tissue is a
key characteristic of obesity and insulin resistance. Despite its emerging importance, the effective
ECM targets remain largely undefined due to limitations of current approaches. Here, we developed
a novel ECM-specific mass spectrometry-based proteomics technique to characterise the global
view of the ECM changes in the skeletal muscle and liver of mice after high fat (HF) diet feeding.
We identified distinct signatures of HF-induced protein changes between skeletal muscle and liver
where the ECM remodelling was more prominent in the muscle than liver. In particular, most muscle
collagen isoforms were increased by HF diet feeding whereas the liver collagens were differentially
but moderately affected highlighting a different role of the ECM remodelling in different tissues of
obesity. Moreover, we identified a novel association between collagen 24α1 and insulin resistance in
the skeletal muscle. Using quantitative gene expression analysis, we extended this association to
the white adipose tissue. Importantly, collagen 24α1 mRNA was increased in the visceral adipose
tissue, but not the subcutaneous adipose tissue of obese diabetic subjects compared to lean controls,
implying a potential pathogenic role of collagen 24α1 in obesity and type 2 diabetes.
Keywords: extracellular matrix; collagen; obesity; diabetes
1. Introduction
Insulin resistance is a hallmark of many metabolic conditions including obesity, Type 2 diabetes,
cardiovascular disease and cancers, therefore representing a potential therapeutic target. A growing
body of evidence suggests a link between the extracellular matrix (ECM) remodelling and insulin
resistance [1,2]. The ECM is composed of the interstitial matrix (e.g., fibrillar collagens, fibronectin,
hyaluronan) and the basement membrane (e.g., collagen IV and laminin), which provide the structural
support for tissues and are required for cell adhesion and migration during growth, differentiation,
morphogenesis and wound healing [3]. Increased deposition of various ECM components (e.g.,
collagens, hyaluronan and osteopontin) and their binding to the ECM receptors (e.g., integrins
and CD44) have been linked to the development of obesity-associated insulin resistance in skeletal
muscle [4–6], adipose tissue [7,8] and the liver [9].
Despite the emerging importance of ECM remodelling in insulin resistance, the effective ECM
targets remain largely undefined. Thus, studies identifying targets in a large scale is immediately
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necessary. Several groups have used approaches that give a more global view of changes such
as oligonucleotide microarray analysis and two-dimensional gel electrophoresis based tandem
mass spectrometry analysis (2-DE/MS-MS) [10,11]. These global analyses have yielded a view
of patterns of changes in pathways and generated new hypotheses. However, changes in mRNA levels
generated from the transcriptomics analysis may not be mirrored by changes in protein abundance [12].
The 2-DE/MS-MS analysis revealed only a few differences in protein abundance and none of those were
ECM proteins [10]. These challenges are addressed in the current study through the use of an initial
decellularisation technique [13]. The decellularisation process greatly removes the cellular components
of the tissue without disrupting the tissue architecture, therefore enriching the ECM proteins and
allowing a comparative proteomic analysis.
Collagens are the most abundant components of the ECM, consisting of three α-helical chains
made of the repetitious amino acid sequence glycine-X-Y, where X and Y are frequently proline or
hydroxyproline. It was previously shown that collagen isoforms I (1), III (3), IV (4), V (5), VI (6) and
XVIII (18) were increased in insulin-resistant tissues [1,14]. Collagen XXIV (24) was discovered as
a new member of the fibril-forming family of collagen molecules and has been demonstrated to be
crucial for osteoblastic differentiation and mineralisation [15,16]. Collagen 24 has not been previously
studied in the context of metabolic regulation or insulin resistance. In the current study, we applied
an ECM-specific mass spectrometry-based proteomics in decellularised tissues to characterise the
complete view of ECM collagen protein changes associated with high fat (HF) diet-induced obesity
and insulin resistance in both skeletal muscle and liver. We found dramatic differences in collagen
signature in muscle and liver and identified collagen 24 α1 as a new collagen isoform, which was
associated with skeletal muscle insulin resistance.
2. Results
2.1. In Vivo Quantitative Proteomics of the ECM Compartment
HF diet (60% fat) feeding in mice for 20 weeks causes obesity, insulin resistance and hepatic
steatosis [9]. The fasting blood glucose was also elevated in HF-fed mice (11.14 ± 0.36 mM, n = 36)
when compared to those in chow-fed control mice (8.55 ± 0.51 mM, n =11) (p < 0.001). To investigate
tissue-specific ECM remodelling in obese mice, gastrocnemius muscle and liver samples were analysed
from mice fed a HF or chow control diet for 20 weeks. The ECM-specific mass spectrometry-based
proteomics detected 78 proteins in muscle, of which 39 (50%) proteins were ECM proteins or contained
ECM regions (full list in Supplemental Table S1). In contrast, 265 proteins were detected in the liver,
of which 181 (68%) proteins were ECM proteins or contained ECM regions (full list in Supplemental
Table S2). These data reveal that the initial decellularisation procedure successfully removed the
majority of abundant cytosolic proteins to improve detection of the lower abundance ECM proteins
(in non-cellularised liver tissues: 92% were cellular proteins; 8% cytoskeletal proteins; 0% ECM
proteins). To test the initial hypothesis that the ECM-related pathways were increased in muscle
and liver of HF-fed obese mice, we performed gene-annotation enrichment analysis and KEGG
(Kyoto Encyclopaedia of Genes and Genomes) pathway mapping using the proteins with a ratio of
HF/Chow >2-fold. Our results showed that in skeletal muscle, differentially increased proteins were
mainly collagen isoform clusters, which were highly involved in pathways including protein digestion
and absorption, ECM–receptor interaction, amoebiasis, platelet activation, focal adhesion and PI3K
(Phosphoinositide 3-kinase)-Akt (Protein kinase B) signalling pathway (Table 1). In contrast, in the
liver 2-fold increased proteins were mainly involved in metabolic pathways such as glycolysis and
gluconeogenesis, metabolism of butanoate, fructose, mannose, pyruvate, carbon, fatty acids and amino
acids (Table 1). In contrast to skeletal muscle, none of the collagen isoforms were mapped to the
enriched pathways in liver. These results highlight a dramatic difference in protein and pathway
changes between muscle and liver, where the ECM remodelling was more prominent in the muscle but
not in the liver.
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Table 1. Gene-annotation enrichment analysis and KEGG (Kyoto Encyclopaedia of Genes and Genomes)
pathway mapping were performed on proteins that were increased by >2-fold in the skeletal muscle and
liver of high fat (HF)-fed mice. The Database for Annotation, Visualisation and Integrated Discovery
(DAVID) v6.8 was used for the analysis and modified Fisher exact p value < 0.05 was used as the
threshold for significance. Count: numbers of genes involved in the term; %: % coverage of involved
genes over total genes in the term; p value: modified Fisher exact p value, the smaller, the more enriched.
Benjamini: FDR (false discovery rate) corrected p values.
Skeletal Muscle
Category Term Count % Genes pValue Benjamini
KEGG_PATHWAY Protein digestionand absorption 6 54.5
COL3A1, COL1A2, COL2A1,
COL1A1, COL24A1, COL5A2 1.75 × 10−10 1.22 × 10−9
KEGG_PATHWAY ECM–receptorinteraction 6 54.5
COL3A1, COL1A2, COL2A1,
COL1A1, COL24A1, COL5A2 1.75 × 10−10 1.22 × 10−9
KEGG_PATHWAY Amoebiasis 6 54.5 COL3A1, COL1A2, COL2A1,COL1A1, COL24A1, COL5A2 7.48 × 10−10 2.62 × 10−9
KEGG_PATHWAY Platelet activation 6 54.5 COL3A1, COL1A2, COL2A1,COL1A1, COL24A1, COL5A2 1.33 × 10−9 3.10 × 10−9
KEGG_PATHWAY Focal adhesion 6 54.5 COL3A1, COL1A2, COL2A1,COL1A1, COL24A1, COL5A2 1.35 × 10−8 2.36 × 10−8
KEGG_PATHWAY
PI3K-Akt
signalling
pathway
6 54.5 COL3A1, COL1A2, COL2A1,COL1A1, COL24A1, COL5A2 1.93 × 10−7 2.70 × 10−7
Liver
Category Term Count % Genes pValue Benjamini
KEGG_PATHWAY Africantrypanosomias-is 4 7.0
HBA-A1, HBA-A2, APOA1,
HBB-B2 7.60 × 10−4 0.058
KEGG_PATHWAY Biosynthesis ofantibiotics 6 10.5
LDHA, ALDOB, FBP1,
ALDH2, HADH, ACAT1 0.005 0.171
KEGG_PATHWAY Glycolysis/Gluconeogenesis 4 7.0
LDHA, ALDOB, FBP1,
ALDH2 0.005 0.118
KEGG_PATHWAY Butanoatemetabolism 3 5.3 HADH, ACAT1, BDH1 0.009 0.156
KEGG_PATHWAY Metabolicpathways 14 24.6
LDHA, SORD, GLUD1,
ALDOB, FBP1, ACAT1, LAP3,
ALDH1A1, PRDX6, BHMT,
ALDH2, ATP5A1, HADH,
BDH1
0.010 0.141
KEGG_PATHWAY Gap junction 4 7.0 TUBB5, TUBA4A, TUBA1A,TUBA1C 0.010 0.123
KEGG_PATHWAY
Fructose and
mannose
metabolism
3 5.3 SORD, ALDOB, FBP1 0.013 0.140
KEGG_PATHWAY Pyruvatemetabolism 3 5.3 LDHA, ALDH2, ACAT1 0.017 0.158
KEGG_PATHWAY Carbonmetabolism 4 7.0
GLUD1, ALDOB, FBP1,
ACAT1 0.022 0.178
KEGG_PATHWAY Tryptophanmetabolism 3 5.3 ALDH2, HADH, ACAT1 0.025 0.179
KEGG_PATHWAY Malaria 3 5.3 HBA-A1, HBA-A2, HBB-B2 0.026 0.170
KEGG_PATHWAY Fatty aciddegradation 3 5.3 ALDH2, HADH, ACAT1 0.027 0.163
KEGG_PATHWAY Lysinedegradation 3 5.3 ALDH2, HADH, ACAT1 0.030 0.167
KEGG_PATHWAY
Valine, leucine
and isoleucine
degradation
3 5.3 ALDH2, HADH, ACAT1 0.033 0.172
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Collagens are the most abundant structural components of the ECM. We further examined the
changes of collagen isoforms. The protein abundance ratio of HF/Chow was >1 in 12 out of the 13
collagen isoforms detected in the skeletal muscle, while Col24α1, Col1α1, Col1α2, Col3α1, Col2α1 and
Col5α2 were increased by >2-fold in the HF-fed mice relative to chow-fed control mice (Figure 1A).
In contrast, in the liver out of the 23 collagen isoforms detected, 11 collagens were shown with a ratio
of HF/Chow >1 (Figure 1B). Moreover, the changes were moderate in liver with exception of a 2.36-fold
increase in Col25α1 in the HF-fed mice relative to chow-fed control mice. These results suggest a
very different signature of collagen changes between insulin-resistant muscle and liver. Unlike in the
skeletal muscle, ECM collagens were not consistently increased by HF diet in liver.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 5 of 14 
 
 
Figure 1. Proteomic detection of collagens in the extracellular matrix (ECM) of skeletal muscle and 
liver of chow- and high fat (HF)-fed mice. Gastrocnemius muscle and liver from chow- and HF-fed 
mice were decellularised by 1% SDS for 5–7 days before subjected to quantitative proteomics using 
iTRAQ (isobaric tags for relative and absolute quantitation) labelling peptide analysis. Data were 
presented as the ratio of the mean of samples from HF-fed mice over the mean of samples from chow-
fed mice. (A) Collagen protein changes in the gastrocnemius muscle. n = 3:3. (B) Collagen protein 
changes in the liver. n = 3:4 (Chow:HF). 
As Col24α1 was increased by >10-fold in the muscle of insulin-resistant mice, we further 
examined its association with diet-induced insulin resistance. Collagen 24α1 is a fibril-forming 
collagen and it was not previously known to be associated with insulin resistance. Using a mouse 
protein–protein interaction database (STRING, www.string-db.org) [17], we showed that collagen 
24α1 interacts with Col1α1, Col1α2, Col2α1, Col3α1 and Col5α2 (Figure 2), therefore providing 
evidence for how collagen 24α1 may be associated with insulin resistance. 
Figure 1. Proteomic detection of collagens in the extracellular matrix (ECM) of skeletal muscle and liver
of chow- and high fat (HF)-fed mice. Gastrocnemius muscle and liver from chow- and HF-fed mice
were decellularised by 1% SDS for 5–7 days before subjected to quantitative proteomics using iTRAQ
(isobaric tags for relative and absolute quantitation) labelling peptide analysis. Data were presented
as the ratio of the mean of samples from HF-fed mice over the mean of samples from chow-fed mice.
(A) Collagen protein changes in the gastrocnemius muscle. n = 3:3. (B) Collagen protein changes in the
liver. n = 3:4 ( how:HF).
As Col24α1 was increased by >10-fold in the muscle of insulin-resistant mice, we further examined
its association with diet-induc insulin resista ce. Collagen 24α1 is a fibril-forming collagen and it
w s not previou ly kn wn to be associated with insulin resistance. Using a mou e prote n–protein
interaction atabase (STRING, www.string-db.org) [17], we showed that collagen 24α1 inter cts with
C l1α1, Col1α2, Col2α1, Col3α1 and Col5α2 (Figure 2), therefore p oviding evidence for ow co la e
may be associated with insulin resistance.
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Figure 2. String network of the collagens that were increased by >2-fold in the muscle of HF-fed
mice. Data was analysed using a mouse protein–protein interaction database (STRING, www.string-db.
org) [17]. Coloured lines represent known or predicted interactions, or other associations as indicated.
2.2. Col24α1 mRNA Was Increased in Skeletal Muscle of HF-Fed Mice
To investigate the mechanism by which collagens were increased in the skeletal muscle of HF-fed
mice, we measured the gene expression of various collagen isoforms. In gastrocnemius muscle,
mRNA levels of Col24α1, Col1α1 and Col3α1 (but not Col1α2) were increased in HF-fed mice relative
to chow-fed mice, suggesting increased Col24α1, Col1α1 and Col3α1 proteins were due to increased
transcripts (Figure 3).
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Figure 3. The mRNA levels of Col24α1, Col1α1, Col1α2, and Col3α1 in gastrocnemius muscle of chow-
and high fat (HF)-fed mice. (A) Col24α1 mRNA expression, n = 8:9 (Chow:HF); (B) Col1α1 mRNA
expression, n = 7:7; (C) Col1α2 mRNA expression, n = 8:7; (D) Col3α1 mRNA expression, n = 6:7.
R lative mRNA expressions were normalised to GAPDH. Data were presented as means ± SEM,
* p < 0.05. HF: high fat.
2.3. Col24α1 mRNA Was Increased in White Adipose Tissue, but Not in Liver of HF-Fed Mice
We further examined whether the Col24α1 gene was correspondingly increas in other metabolic
tissues of HF-fed mice and found that Col24α1 mRNAs were increased in epididymal white adipose
tissue (WAT) and superficial vastus lateralis, but not in the liver (Figure 4). In epididymal adipose
tissue, Col24α1 was increased by 5-fold (Figure 4A), relative to a 1.5–2-fold increase in skeletal muscle
including gastrocnemius (Figure 3A) and the superficial vastus lateralis (Figure 4C).
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Figure 4. The mRNA levels of Col24α1 in other metabolic tissues of chow- and high fat (HF)-fed mice.
Col24α1 mRNA expression was measured in epididymal adipose tissue ((A), n = 5:6), liver ((B), n = 6:6),
and the superficial vastus lateralis ((C), n = 6:5). Relative mRNA expression was normalised to 18s in
epididymal adipose tissue and GAPDH in liver and vastus. Data were presented as means ± SEM, * =
p < 0.05. HF: high fat. WAT: white adipose tissue.
2.4. Col24α1 mRNA Was Increased in Visceral Adipose Tissue of Obese Diabetic Human Subjects
As Col24α1 gene expression was most differentially upregulated in the adipose tissue of obese
mice by HF diet, we assessed its expression in human adipose tissue (a thropometric data of human
subjects shown in Supplemental Table S3). Col24α1 mRNA was increased in the visceral adip se tissue,
but not the subcutaneous adipose tissue of obese diabetic subjects compared to lean subjects (Figure 5).
In contrast, Col24α1 mRNA was decreased in the subcutaneous adipose tissue, but was unchanged in
the visceral adipose tissue of obese subjects compared to lean s jects (Figure 5).
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Figure 5. The mRNA levels of Col24α1 in white adipose tissue of lean, obese, obese and diabetic
subjects. Col24α1 mRNA expression was measured in human visceral adipose tissue (VAT) ((A), n
= 9:9:8) and subcutaneous adipose tissues (SAT) ((B), n = 6:9:8). Relative mRNA expressions were
normalised to 18s. Data were presented as means ± SEM, * = p < 0.05. VAT: visceral adipose tissue;
SAT: subcutaneous adipose tissue; T2DM: Type 2 diabetes mellitus.
3. Discussion
Our current study applied an ECM-specific mass spectrometry-based proteomics to characterise
the complete view of ECM protein changes associated with high fat (HF) diet feeding in mice.
We identified, for the first time, significant differences in protein and pathway changes between muscle
and liver. In the skeletal muscle, the ECM-related pathways were shown to be increased. Yet in the liver
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HF diet-associated changes were mainly pathways involved in metabolism. In particular, the ECM
collagen changes were distinct between the insulin-resistant skeletal muscle and liver, where the
majority of muscle collagen isoforms were increased whereas the liver collagens were differentially but
moderately affected. Moreover, we identified a novel association between collagen 24α1 and insulin
resistance in the skeletal muscle and adipose tissue. Increased collagen 24α1 was further seen in the
visceral adipose tissue of obese diabetic subjects relative to lean controls, suggesting a potential role of
collagen 24α1 in the pathogenesis of insulin resistance, obesity and Type 2 diabetes in mice and human.
Studies of the role of specific ECM components in insulin resistance are pivotal but incomplete.
This is mainly due to limitations of current approaches that give a more global view of changes such
as oligonucleotide microarray analysis and two-dimensional gel electrophoresis based tandem MS
analysis (2-DE/MS-MS) [10,11], where oligonucleotide microarray analysis only detects changes in
mRNA levels. Due to the low abundance of ECM proteins relative to most of the cytosolic proteins,
detections of ECM proteins by 2-DE/MS-MS were difficult and insufficient. The key step in proteomic
analysis of the ECM is their isolation. One traditional method is to homogenise the whole tissue then
to separate the ECM by centrifugation [18]. The challenges with this method are contamination with
proteins from damaged cells and the disruption of the ECM architecture. We refined methods to
minimise contamination and disruption of the ECM using an in situ isolation approach by detergent,
SDS [13], which leaves the ECM protein enriched and structure intact. Although preliminary due to the
low sample size, our proteomics data are consistent with findings from other biochemical approaches
specifically in skeletal muscle [19,20], therefore provide evidence for the ECM-based proteomics as a
powerful tool in ECM-related research.
It is significant to see the different pathway changes between the insulin-resistant skeletal muscle
and liver of obese mice. We detected less ECM proteins in muscle relative to liver, indeed fewer overall
proteins (78 proteins in muscle relative to 265 proteins in liver, Supplemental Tables S1 and S2). This
could be due to a more complex cellular components of the liver consisting of multiple cell types,
primarily parenchymal cells (hepatocytes) and non-parenchymal cells (kupffer cells, hepatic stellate
cells and liver sinusoidal endothelial cells). However, the skeletal muscle is primarily made of muscle
fibres from myocytes surrounded by connective tissues. The majority of the ECM collagens were
increased in muscle of obese mice suggesting a remodelling towards a more fibrotic state. This is
consistent with various previous studies both in mice and human [19,21,22]. However, the liver of
obese mice had a balanced and moderate remodelling which may result from more dynamic changes
of cell types during obesity [23]. Indeed, the gene-annotation enrichment analysis suggests that the
ECM-related pathways were only enriched in the muscle, but not in the liver, suggesting that the
ECM remodelling may be more prominent and influential in the muscle. It is worth noting that
various isoforms of keratin were also found to be increased in muscle of HF-fed mice by proteomics
(Supplemental Table S1). Since no indication of a role of keratin in obesity and insulin resistance,
future in-depth investigations will be important and are needed.
Increased collagen protein in insulin-resistant skeletal muscle was shown to be associated with
increased mRNA levels. In gastrocnemius muscle, the mRNAs of Col24α1, Col1α1 and Col3α1 were
increased by HF diet feeding. These results were consistent with previous results by us [4] and
others [22]. The increased protein expression of Col1 and Col3 has also been shown in insulin-resistant
skeletal muscle in human [22,24] and mice [4]. Increased collagen protein expression could also be due
to decreased degradation by matrix metalloproteinases or MMPs. It has been shown that in skeletal
muscle increased collagen protein was due to decreased enzymatic activity of MMP9 [4]. Moreover,
genetic deletion of mmp9 gene resulting in increased protein expression of Col3 and Col4 in the muscle,
exacerbated HF diet-induced insulin resistance in muscle [25]. Taken together, these results suggest
that our data are consistent with previous findings, yet identified a novel association between increased
Col24α1 and muscle insulin resistance.
To further establish how Col24α1 may be associated with insulin resistance, we showed that
Col24α1 interacts with Col1α1, Col1α2, Col2α1, Col3α1 and Col5α2 from a string networking analysis
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of the collagens [17]. These results suggest that Col24α1 may regulate or interact with other collagen
isoforms that have been shown to be remodelled during muscle insulin resistance, therefore influencing
metabolism during excess caloric intake such as HF feeding. Unfortunately, due to the unavailability of
a functional collagen 24 antibody, we were unable to further investigate its regulation and interactome.
Although Col24α1 protein was increased by >10-fold in the muscle, its mRNA level was most
increased in the white adipose tissue of mice (5-fold) when compared with gastrocnemius muscle
(1.5-fold) and superficial vastus lateralis (2-fold). Increased Col24α1 mRNAs in the white adipose
tissue of obese mice were consistent with previously reported increases in mRNAs of other collagen
isoforms including Col5α2, Col6α2, Col6α3 and Col18α1 [7,26–28]. While these studies identified crucial
roles of collagens 6 and 18 in the pathogenesis of insulin resistance in obese mice, our studies imply a
potential role of collagen 24 in diet-induced insulin resistance. Collagen 24 knockout mice will provide
a valuable tool for future investigations.
It has been previously shown that increased collagen deposition is also manifested in human
adipose tissue where Col6α3 mRNA was increased in the subcutaneous abdominal and gluteal adipose
tissue of metabolically obese subjects [29]. Here we showed that Col24α1 mRNA was not changed
in the visceral adipose tissue but decreased in the subcutaneous adipose tissue of obese subjects.
These disparities could be due to differences in the study populations, where Khan et al. studied obese
Asian Indians relative to Caucasian controls whereas our study compared obese subjects and lean
controls of all Caucasian European descendants [29]. Interestingly, the mRNA levels of Col24α1 were
indeed increased in the visceral adipose tissue, but not in the subcutaneous adipose tissue of obese and
diabetic subjects relative to lean controls. In humans, visceral adipose tissue is associated with insulin
resistance, dyslipidaemia and Type 2 diabetes, while subcutaneous adipose tissue is associated with
preserved insulin sensitivity and mitigates risk of metabolic disorders [30–32]. Moreover, in vitro study
revealed that adipocytes from visceral adipose tissue rather than subcutaneous adipose tissue of obese
mice showed impaired insulin-stimulated glucose uptake, adipogenesis ability and ECM remodelling
representing dysfunctional adipocytes [33]. Thus, our result that Col24α1 mRNA expression was
increased in the visceral adipose tissue of obese and diabetic subjects but not in the subcutaneous
adipose tissue implied a potential pathogenic role of Col24α1 in obesity and Type 2 diabetes. Col24α1
was previously identified as a minor type V collagen [34] and mice with genetic deletion of Col24α1
were fertile, suggesting that it is not an essential structural protein of the ECM. Therefore, Col24α1
may represent a novel therapeutic target of obesity-related metabolic disorders.
In conclusion, using extracellular compartment-specific proteomics technique we characterised
the complete view of ECM changes that were associated with HF diet feeding in skeletal muscle
and liver of mice. The distinct signatures of collagen changes between muscle and liver highlight
a different role of the ECM remodelling in different tissues of obesity. Furthermore, we identified a
novel association between collagen 24α1 and insulin resistance in muscle and white adipose tissue,
providing evidence for a potential role of collagen 24α1 in the pathogenesis of diet-induced insulin
resistance in these tissues.
4. Materials and Methods
4.1. Animal Models
Male C57BL/6J mice were housed in a temperature (22 ± 1 ◦C) and humidity-controlled room
with a 12 h light/dark cycle. Mice were fed either a chow control diet (D/811004; Special Diets Services,
Essex, UK) containing around 13% total proteins, 84% carbohydrates and 3% fat or a 60% high fat (HF,
primarily lard-based) diet (824054; Special Diets Services, Essex, UK) for 20 weeks starting at 6 weeks of
age. Mice had free access to food and water. Only male mice were used in this study due to their high
susceptibility to a robust insulin resistant phenotype after HF feeding. To confirm the hyperglycaemia
phenotype, mice were fasted for 5 h in the morning before a blood glucose measurement from the tail
vein. All procedures were performed under the UK Home Office Project Licence (P05F71E15; Date of
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issue 3 May 2019) following the ARRIVE guidelines and were approved by the Welfare and Ethical
Use of Animals Committee at the University of Dundee.
4.2. ECM-Specific Mass Spectrometry-Based Proteomics
4.2.1. Isolation of the ECM
Gastrocnemius muscle and liver were collected from 5 h fasted mice (morning fasting). Three or
four mice were used for each dietary group. The ECM compartments of the tissues were isolated
using an in situ approach by detergent SDS [13]. Gastrocnemius from one leg and ≈500 mg liver
were incubated with 1% SDS at 4 ◦C for 5–7 days. The 1% SDS was changed daily. At the end of
the incubation, tissue remains were weighed, frozen and grinded in liquid nitrogen. For proteomics
studies, frozen samples were dissolved in 8 M guanidine with 100 mM dithiothreitol and heated.
Iodoacetamide (200 mM) was then added and incubated for 45 min at room temperature in the dark.
Samples were diluted to achieve a final concentration of 1M guanidine for trypsin digestion. In vivo
quantitative proteomics of the ECM compartment in chow- and HF-fed mice were performed using
iTRAQ (Isobaric tags for relative and absolute quantitation) labelling.
4.2.2. iTRAQ Labelling Peptide Analysis by LC-MS/MS
Peptide concentration was determined by the bicinchoninic acid (BCA) assay and 100 µg peptides
from each sample were used for the assay. Peptides were labelled with iTRAQ four-plex (AB Sciex,
Warrington, UK) as previously described [35] and analysed by the LC-MS (Liquid chromatography-mass
spectrometry) /MS [36]. Peptides were separated by an Easy nLC-1000 pump connected to an
autosampler system (ThermoFisher Scientific, Bremen, Germany) and analysed by a Q-Exactive
mass spectrometer (ThermoFisher Scientific, Bremen, Germany) equipped with nanoelectrospray.
All resulting MS/MS spectra were assigned to peptides using the IPI (International Protein Index) mouse
database version 3.83 by the PEAKS software v.8.5 (Bioinformatics solutions Inc, Waterloo, ON, Canada).
Mass tolerance for precursor ions and fragment ions was set to 7 and 10 ppm, respectively. Searches
of the MS/MS spectra incorporated fixed modifications of carbamidomethylation of cysteines and
iTRAQ four-plex modification of lysines and peptide N termini, as well as the variable modifications
of oxidation of methionine, and phosphorylation of serine, threonine and tyrosine residues. Samples
(n = 3–4 mice per group) were run on two separate iTRAQ four-plex assays. All data were normalised
to one sample from the chow-fed group that was run on both assays as inter-assay control for each
protein. Changes of protein abundance caused by HF feeding was presented as the ratio of the mean
of samples from HF-fed mice over the mean of samples from chow-fed mice.
4.3. Gene-Annotation Enrichment Analysis and KEGG Pathway Mapping
The Database for Annotation, Visualisation and Integrated Discovery (DAVID) v6.8 (https:
//david.ncifcrf.gov/home.jsp) was used for the pathway enrichment analysis [37,38]. Proteins that were
shown with a ratio of HF/Chow > 2 from the proteomics study were converted to their corresponding
gene IDs. The gene list was uploaded, and the functional annotation analysis was run using Mus
musculus selected as the species and background. The KEGG pathway was mapped using count
threshold of 3 and EASE (modified Fisher exact p value) threshold of 0.05.
4.4. String Network Analysis
Protein–protein associations were determined using the STRING (v.11.0) database (www.string-
db.org; ELIXIR, Cambridgeshire, UK) [17], which collect, score and integrate all publicly available
sources of protein–protein interaction information, and to complement these with computational
predictions. The corresponding gene IDs were used as identifiers.
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4.5. Mouse Tissue Collection and Preparation
Mouse tissues were collected from 5 h fasted mice (morning fasting). RNA was isolated from
epididymal adipose tissue, gastrocnemius, superficial vastus lateralis or liver samples. Briefly,
30–100 mg tissues were weighed into 1 mL Trizol (93289; Sigma Aldrich, Dorset, UK), lysed by bullet
blender and centrifuged at 13,000 rpm for 15 min. The lysates were then treated with chloroform,
isopropanol and 75% ethanol to extract RNAs and the total RNAs were dissolved in 30 µL nuclease
free water and concentration determined by nanodrop. Then, 1 µg total RNAs were transcribed to
cDNAs by SuperScript TM Reverse Transciptase (18064022; ThermoFisher, Perth, UK), according to the
manufacturer’s protocol. cDNAs were diluted 20 times before running real-time PCR.
4.6. Human Sample Collection and Preparation
Paired human subcutaneous and visceral adipose tissue samples were obtained from subjects
undergoing elective abdominal surgery at the Royal Infirmary of Edinburgh. Superficial subcutaneous
tissue was obtained at the incision between the overlying skin and the muscles of the anterior abdominal
wall. Visceral tissue was obtained from either omental or mesenteric depot. Samples were obtained
from the Edinburgh adipose tissue bank (part of the Lothian NRS Human Annotated Bioresource).
Ethical approval was obtained from the East of Scotland Research Ethics Service (15/ES/0094, approved
15 July 2015) and informed consent was obtained from each participant. Samples were immediately
frozen at −80 ◦C until analysis. Then, 30–50 mg tissues were used for total RNA extraction and 2 µg
total RNAs were transcribed to cDNAs as described above.
4.7. Measurement of Gene Expression by Real-Time PCR
Quantitative PCR were performed using the TaqMan® Gene Expression assay (ThermoFisher,
Perth, UK) for mouse collagen24α1 (Mm013237744_m1), human collagen24α1 (Hs00537706_m1),
mouse collagen1α1 (Mm00801666_g1), mouse collagen1α2 (Mm00483888_m1), mouse collagen3α1
(Mm00802331_m1). 18s (Hs99999901_s1) was used as reference controls in human and mouse adipose
tissue. Mouse GAPDH (Mm99999915_g1) was used as reference control in the other tissues.
4.8. Statistical Analyses
Data were expressed as mean ± SEM. Proteomics data were presented as HF/Chow ratios.
Real-time PCR data were calculated by 2−∆∆Ct using 18 s or GAPDH as reference genes. Statistical
analyses were performed using either unpaired Student’s t-test or one-way ANOVA as appropriate
and figures were generated by GraphPad Prism software of v.8.4.2 (GraphPad Software, San Diego,
CA, USA).The significance level was at p < 0.05.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/21/16/
5738/s1.
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Abbreviations
Akt Protein kinase B
BCA Bicinchoninic acid
ECM Extracellular matrix
HF High fat
iTRAQ Isobaric tags for relative and absolute quantitation
KEGG Kyoto Encyclopaedia of Genes and Genomes
LC-MS Liquid chromatography-mass spectrometry
MMPs Matrix metalloproteinases
MMP9 Matrix metalloproteinases 9
MSPI3K Mass spectrometry
PI3K Phosphoinositide 3-kinase
SAT Subcutaneous adipose tissue
SDS Sodium dodecyl sulfate
2-DE Two-dimensional gel electrophoresis
VAT Visceral adipose tissue
WAT White adipose tissue
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